Entasis Therapeutics Holdings Inc.
ETTX
ETTX was delisted on the 8th of July, 2022.
20 hedge funds and large institutions have $34.8M invested in Entasis Therapeutics Holdings Inc. in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 9 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
5% more funds holding
Funds holding: 19 → 20 (+1)
63% less capital invested
Capital invested by funds: $93.1M → $34.8M (-$58.3M)
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Blackstone Inc
New York
|
+$10.7M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$961K |
| 3 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$705K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$323K |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$273K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HP
Hound Partners
New York
|
-$1.12M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$757K |
| 3 |
Goldman Sachs
New York
|
-$545K |
| 4 |
LCM
Laurion Capital Management
New York
|
-$544K |
| 5 |
Norges Bank
Oslo,
Norway
|
-$544K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
26
Parallel Advisors
San Francisco,
California
| – | -$7K | -600 | Closed |
|
|
CCA
27
Catalyst Capital Advisors
Huntington,
New York
| – | -$5K | -466 | Closed |
|
28
Morgan Stanley
New York
| – | +$448 | +68 | New |
|
29
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | +$1.37K | +208 | New |
|
ETTX Hedge Fund Activity: Q4 2018 in Review
20 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Entasis Therapeutics Holdings Inc. (ETTX) for Q4 2018, worth a combined $34.8M — down 63% from $93.1M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new ETTX positions and 9 closed out — a net gain of 2 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Blackstone Inc, opening a new position worth an estimated $10.7M. The largest seller was Hound Partners, exiting entirely with an estimated $1.12M sold.
- 20 institutional investors held Entasis Therapeutics Holdings Inc. (ETTX) as of Q4 2018, up from 19 in Q3 2018.
- Funds reported $34.8M of Entasis Therapeutics Holdings Inc. stock for Q4 2018, down 63% quarter-over-quarter.
- 11 funds opened new Entasis Therapeutics Holdings Inc. positions in Q4 2018 and 9 closed out, a net change of +2 holders.
- The largest Entasis Therapeutics Holdings Inc. buyer in Q4 2018 was Blackstone Inc, an estimated $10.7M added.
- The largest Entasis Therapeutics Holdings Inc. seller in Q4 2018 was Hound Partners, an estimated $1.12M sold.
Based on aggregated 13F filings for Q4 2018.